Moffitt logo

Clinical Trials Search

Clinical Trial 21142

Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#:

Phase: Phase I
Principal Investigator: Sallman, David

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

A Phase 1b, Multicenter, Open-label Platform Study of Select Drug Combinations in Adult Patients with Lower Risk (Very Low, Low, or Intermediate Risk) Myelodysplastic Syndrome (CMBG453E12101)

Summary

Objective

Treatments

Therapies

Immunotherapy; Therapy (NOS)

Medications

Canakinumab (); MBG453 (); NIS793 ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.